Status:
UNKNOWN
Benigh Prosatic Hyperplasia/Lower Urinary Tract Symptoms
Lead Sponsor:
The Third Affiliated hospital of Zhejiang Chinese Medical University
Conditions:
Benign Prostatic Hyperplasia
Lower Urinary Tract Symptoms
Eligibility:
MALE
40-80 years
Phase:
NA
Brief Summary
Benign prostatic hyperplasia (BPH) is a common condition in aging men that is frequently associated with troublesome lower urinary tract symptoms (LUTS) which can be divided into storage phase symptom...
Eligibility Criteria
Inclusion
- Diagnosis of BPH in accordance with the criteria of the Chinese Urological Diagnosis and Treatment Guidelines 2014 edition.
- Male patients aged 40-80 years.
- Not on any 5a-reductase inhibitor, a1 receptor blocker or traditional Chinese medicine in the past two weeks.
- International Prostate Symptom Score (IPSS) scores range from 1 to 19.
- Family members or patients give informed consent and sign informed consent.
Exclusion
- Patients with recurrent urinary tract infections.
- Patients with neurogenic bladder and urethral stricture, bladder tumor and prostate cancer.
- Patients with benign prostatic obstruction who have failed invasive treatment.
- Patients with serious cardiovascular and cerebrovascular diseases, hematopoietic system and other primary diseases and mental disorders.
- Patients who are participating in other clinical trials or who are participating in other clinical trials within one month.
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT05288621
Start Date
April 1 2022
End Date
December 30 2024
Last Update
April 4 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.